Every recall we track for K.C. Pharmaceuticals, Inc — 15 in all — plus the complaints and injury reports the public filed about them.
K.C. Pharmaceuticals recalls sterile eye drops that may not be sterile, risking infection. Affected lots expire 09/30/26. Consumers should contact the manufacturer for details.
K.C. Pharmaceuticals recalls sterile eye drops AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%) due to lack of assurance of sterility. This could lead to infections if used.
K.C. Pharmaceuticals recalls EYE DROPS Advanced Relief with potential lack of sterility. Consumers should stop using affected lots to avoid infection risks.
K.C. Pharmaceuticals recalls sterile eye drops for redness relief that may not be sterile, posing a risk of infection. Consumers should check product details and contact the manufacturer for guidance.
K.C. Pharmaceuticals recalls 0.5 fl oz dry eye relief eye drops due to lack of assurance of sterility. Consumers should check product labels for NDC 57896-181-05 or similar identifiers.
K.C. Pharmaceuticals recalls sterile eye drops (tetrahydrozoline HCl 0.05%) that may not be sterile, posing infection risks. Consumers should check product details and contact the manufacturer.
K.C. Pharmaceuticals recalls sterile 0.5 fl oz eye drops due to lack of assurance of sterility. Consumers should check product labels for NDC 70000-0457-1 or similar codes to determine if affected.
K.C. Pharmaceuticals recalls sterile lubricant eye drops with potential contamination risk. Products sold under various brand names and distributed by Cardinal Health, Perrigo Direct, and others. Consumers should check labels for specific lot numbers and expiration dates.
K.C. Pharmaceuticals recalls 0.5 fl oz dry eye relief eye drops with CGMP deviations in fill line documentation. Consumers should check product labels for lot numbers and expiration dates.
